Zoetis Inc (NYSE:ZTS)

94.43
Delayed Data
As of 4:00pm ET
 -0.84 / -0.88%
Today’s Change
68.56
Today|||52-Week Range
96.57
+31.08%
Year-to-Date
Can Zoetis (ZTS) Stock Continue to Grow Earnings?
9:42am / Zacks.com - Paid Partner Content
Zoetis (ZTS) Q3 Earnings & Revenues Surpass Estimates
Nov 01 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View
Nov 01 / Zacks.com - Paid Partner Content
Should You Buy Zoetis (ZTS) Ahead of Earnings?
Oct 31 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Tops Q3 Earnings and Revenue Estimates
Nov 01 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close95.27
Today’s open95.18
Day’s range94.14 - 95.57
Volume2,120,790
Average volume (3 months)2,325,836
Market cap$45.8B
Data as of 4:00pm ET, 11/12/2018

Growth & Valuation

Earnings growth (last year)+6.02%
Earnings growth (this year)+29.57%
Earnings growth (next 5 years)+15.30%
Revenue growth (last year)+8.57%
P/E ratio39.7
Price/Sales6.69
Price/Book26.17

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-7.70-4.26%
CELGCelgene-2.87-3.88%
REGNRegeneron Pharmaceut...-10.10-2.83%
SHPGShire+1.64+0.91%
Data as of 5:26pm ET, 11/12/2018

Financials

Next reporting dateFebruary 12, 2019
EPS forecast (this quarter)$0.77
Annual revenue (last year)$5.3B
Annual profit (last year)$864.0M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts